A variety of disciplines including noninvasive and invasive cardiac me
thodologies, as well as epidemiologic studies, have provided informati
on that has altered our view on the relation of diabetes to cardiac di
sease. Instead of an exclusive focus on coronary artery disease, it is
now recognized that heart muscle can be independently involved in dia
betic patients. In diabetics without known cardiac disease, abnormalit
ies of left ventricular mechanical function have been demonstrated in
40 to 50% of subjects, and it is primarily a diastolic phenomenon. Lef
t ventricular hypertrophy may eventually appear in the absence of hype
rtension. The diastolic dysfunction appears related to interstitial co
llagen deposition, largely attributable to diminished degradation. The
presence of even moderate obesity intensifies the abnormality. Revers
ibility of this process is not readily achieved with chronic insulin t
herapy. Experimental studies have indicated normalization of the colla
gen alteration by endurance training, begun relatively early in the di
sease process. General measures of management include the control of o
ther cardiac risk factors and a reasonable program of physical activit
y. The high mortality during an initial acute myocardial infarction ha
s been attributed to heart failure, which is managed as in nondiabetic
patients. Recently, the early introduction of aspirin, thrombolysis,
and beta-adrenergic blockade has reduced mortality during the initial
infarction. Chronic use of the latter agent over the subsequent years
has also proven to be more beneficial in diabetic patients with acute
myocardial infarction compared with nondiabetic patients.